Ad
BBC - Virtus LifeSci Biotech Clinical Trials Stock Trading
About | Virtus LifeSci Biotech Clinical Trials (NYSE:BBC)
None
Quote | Virtus LifeSci Biotech Clinical Trials (NYSE:BBC)
| Last: | $19.30 |
|---|---|
| Change Percent: | -1.63% |
| Open: | $19.39 |
| Close: | $19.62 |
| High: | $19.396 |
| Low: | $19.3 |
| Volume: | 974 |
| Last Trade Date Time: | 09/28/2023 03:00:00 am |
News | Virtus LifeSci Biotech Clinical Trials (NYSE:BBC)
-
2023-09-22 03:30:00 ET Summary Healthcare stocks often serve as powerful painkillers during market declines. While the MSCI World Index fell by 18.1% in 2022, healthcare stocks fell by only 5.4%. Investing effectively in healthcare stocks requires a unique set of skills. ...
-
2023-08-16 02:28:00 ET Summary Risk-on sentiment and end of pandemic boom have weighed on healthcare. Health insurers and medical device firms have held up better. Growing opportunity in obesity treatments. Tarik Aeta, Global Healthcare Analyst with TD Asset Mana...
Message Board Posts | Virtus LifeSci Biotech Clinical Trials (NYSE:BBC)
| Subject | By | Source | When |
|---|---|---|---|
| Biotechs' Second-Half Battle | stockguard | investorshub | 07/22/2019 7:16:46 PM |
| Big pharmas billion-dollar bets | stockguard | investorshub | 06/14/2019 8:21:04 PM |
| How high will the Healthcare/Biotech sector go in 2019? | stockguard | investorshub | 04/05/2019 5:29:49 PM |
| Biotech Is Worth The Hype, But Do You | stockguard | investorshub | 03/02/2019 7:01:31 PM |
| IBB: This Is Only The Beginning | stockguard | investorshub | 02/19/2019 7:31:14 PM |
Virtus LifeSci Biotech Clinical Trials Company Name:
BBC Stock Symbol:
NYSE Market:
Ad
-
Windsor, Berkshire, United Kingdom - ( NewMediaWire ) - December 15, 2022 - Argentum 47, Inc. ("Argentum" or the "Company") ( www.argq.io ) (OTC PINK: ARGQ), a provider of comprehensive artificial intelligence enhanced digital marketing services, including branding, advertising, and lead genera...
-
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants to invest in multiple biotech companies via one vehicle. The life science sector certainly holds a risk factor, and ETFs are a good wa...
-
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants to invest in multiple biotech companies via one vehicle. The life science sector certainly holds a risk factor, and ETFs are a good way to enter th...